Intellect Neurosciences, Inc. Announces Independent Studies On Copper Binding Properties Of Its Lead Candidate OXIGON(TM)

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer’s disease (”AD”), announced today that the chemical structure of OXIGON(TM) (indole-3-propionic acid) has been independently shown to form copper complexes.

More: continued here









Leave a Reply